Gene expression in papillary thyroid carcinoma reveals highly consistent profiles

Papillary thyroid carcinoma (PTC) is clinically heterogeneous. Apart from an association with ionizing radiation, the etiology and molecular biology of PTC is poorly understood. We used oligo-based DNA arrays to study the expression profiles of eight matched pairs of normal thyroid and PTC tissues. Additional PTC tumors and other tissues were studied by reverse transcriptase–PCR and immunohistochemistry. The PTCs showed concordant expression of many genes and distinct clustered profiles. Genes with increased expression in PTC included many encoding adhesion and extracellular matrix proteins. Expression was increased in 8/8 tumors for 24 genes and in 7/8 tumors for 22 genes. Among these genes were several previously known to be overexpressed in PTC, such as MET, LGALS3, KRT19, DPP4, MDK, TIMP1, and FN1. The numerous additional genes include CITED1, CHI3L1, ODZ1, N33, SFTPB, and SCEL. Reverse transcriptase–PCR showed high expression of CITED1, CHI3L1, ODZ1, and SCEL in 6/6 additional PTCs. Immunohistochemical analysis detected CITED1 and SFTPB in 49/52 and 39/52 PTCs, respectively, but not in follicular thyroid carcinoma and normal thyroid tissue. Genes underexpressed in PTC included tumor suppressors, thyroid function-related proteins, and fatty acid binding proteins. Expression was decreased in 7/8 tumors for eight genes and decreased in 6/8 tumors for 19 genes. We conclude that, despite its clinical heterogeneity, PTC is characterized by consistent and specific molecular changes. These findings reveal clues to the molecular pathways involved in PTC and may provide biomarkers for clinical use.

[1]  H. Rabes,et al.  The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas , 1999, Oncogene.

[2]  F. Matsuzuka,et al.  Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma. , 1997, Cancer research.

[3]  R. Palmiter,et al.  Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Takano,et al.  Rapid screening of specific changes in mRNA in thyroid carcinomas by sequence specific‐differential display: Decreased expression of acid ceramidase mRNA in malignant and benign thyroid tumors , 1999, International journal of cancer.

[5]  J. Whitsett,et al.  Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. , 1999, Human pathology.

[6]  J. Hur,et al.  Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. , 2001, Genes & development.

[7]  J. Lillehaug,et al.  Difference in Patterns of Met Expression in Papillary Thyroid Carcinomas and Nonneoplastic Thyroid Tissue , 2001, World Journal of Surgery.

[8]  T. Terada,et al.  Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas , 2001, Virchows Archiv.

[9]  L. Weiss,et al.  Familial papillary carcinoma of the thyroid. , 1986, American journal of medical genetics.

[10]  C. Figueroa,et al.  Alpha1-Antitrypsin Expression in Human Thyroid Papillary Carcinoma , 1996 .

[11]  N. Tronko,et al.  Childhood thyroid cancer since accident at Chernobyl , 1995, BMJ.

[12]  M H Skolnick,et al.  Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. , 1994, Journal of the National Cancer Institute.

[13]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Ghoshal,et al.  Suppression of Metallothionein Gene Expression in a Rat Hepatoma Because of Promoter-specific DNA Methylation* , 2000, The Journal of Biological Chemistry.

[16]  M. Weiss,et al.  Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene , 1996, International journal of cancer.

[17]  K. Franssila,et al.  Neoexpression of the epithelial adhesion complex antigens in thyroid tumours is associated with proliferation and squamous differentiation markers , 1998, The Journal of pathology.

[18]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[19]  C. Cheung,et al.  Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma , 2001, Modern Pathology.

[20]  A. Pinchera,et al.  RET proto-oncogene mutations in thyroid carcinomas: Clinical relevance , 2000, Journal of endocrinological investigation.

[21]  A. Miyauchi,et al.  Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: a possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas. , 2000, The Journal of clinical endocrinology and metabolism.

[22]  E. Campo,et al.  GALECTIN‐3 AND LAMININ EXPRESSION IN NEOPLASTIC AND NON‐NEOPLASTIC THYROID TISSUE , 1997, The Journal of pathology.

[23]  G. Brabant,et al.  Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues. , 2009, Experimental and clinical endocrinology.

[24]  H. Gharib,et al.  Nodular thyroid disease. Evaluation and management. , 1985, The New England journal of medicine.

[25]  K. Umeki,et al.  CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma , 1995, International journal of cancer.

[26]  T. Terada,et al.  Immunohistochemical and In Situ Hybridization Analyses of Midkine Expression in Thyroid Papillary Carcinoma , 2000, Modern Pathology.

[27]  D. Nostrand,et al.  Thyroid cancer : a comprehensive guide to clinical management , 2000 .

[28]  W. Isaacs,et al.  Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. , 1996, Genomics.

[29]  C. Betsholtz,et al.  EPS8 and E3B1 transduce signals from Ras to Rac , 1999, Nature.

[30]  P. Inskip.  Thyroid cancer after radiotherapy for childhood cancer. , 2001, Medical and pediatric oncology.

[31]  A. Miyauchi,et al.  Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. , 1999, Cancer research.

[32]  H. Nielsen,et al.  Serum YKL-40 and colorectal cancer , 1999, British Journal of Cancer.